Robin E. Buckingham

11.4k total citations
62 papers, 4.8k citations indexed

About

Robin E. Buckingham is a scholar working on Molecular Biology, Physiology and Endocrine and Autonomic Systems. According to data from OpenAlex, Robin E. Buckingham has authored 62 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Physiology and 19 papers in Endocrine and Autonomic Systems. Recurrent topics in Robin E. Buckingham's work include Peroxisome Proliferator-Activated Receptors (19 papers), Regulation of Appetite and Obesity (18 papers) and Adipose Tissue and Metabolism (17 papers). Robin E. Buckingham is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (19 papers), Regulation of Appetite and Obesity (18 papers) and Adipose Tissue and Metabolism (17 papers). Robin E. Buckingham collaborates with scholars based in United Kingdom, United States and Canada. Robin E. Buckingham's co-authors include Jonathan R.S. Arch, Peter Widdowson, Mohammad Tadayyon, Shelagh Wilson, Thomas C. Hamilton, G. Williams, John C. Clapham, John Wilding, Lucy Pickavance and Kieran Clarke and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Diabetes.

In The Last Decade

Robin E. Buckingham

62 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin E. Buckingham United Kingdom 33 2.0k 1.4k 1.2k 858 850 62 4.8k
John C. Clapham United Kingdom 30 2.1k 1.1× 742 0.5× 1.9k 1.6× 355 0.4× 364 0.4× 72 4.3k
Martin Heni Germany 45 1.1k 0.6× 1.6k 1.2× 2.2k 1.9× 681 0.8× 1.4k 1.7× 204 6.4k
Björn Lemmer Germany 38 1.0k 0.5× 1.6k 1.1× 1.3k 1.1× 1.3k 1.5× 350 0.4× 183 5.1k
Stefan Trapp United Kingdom 38 1.6k 0.8× 1.5k 1.1× 760 0.6× 618 0.7× 1.5k 1.7× 74 5.0k
Judith Harvey‐White United States 38 1.2k 0.6× 1.0k 0.7× 1.6k 1.3× 244 0.3× 1.9k 2.3× 66 7.3k
Jean‐Pierre Maffrand France 36 1.6k 0.8× 677 0.5× 629 0.5× 1.3k 1.5× 570 0.7× 90 5.8k
Alessandro Pocai United States 33 2.1k 1.1× 2.0k 1.4× 2.2k 1.9× 334 0.4× 1.5k 1.7× 55 5.9k
William J. Louis Australia 38 1.1k 0.5× 378 0.3× 706 0.6× 1.2k 1.4× 465 0.5× 207 4.6k
Anders Fink‐Jensen Denmark 43 1.9k 1.0× 673 0.5× 803 0.7× 236 0.3× 1.1k 1.3× 170 5.3k
Mariano Ruiz‐Gayo Spain 32 738 0.4× 661 0.5× 1.1k 0.9× 677 0.8× 214 0.3× 99 3.2k

Countries citing papers authored by Robin E. Buckingham

Since Specialization
Citations

This map shows the geographic impact of Robin E. Buckingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin E. Buckingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin E. Buckingham more than expected).

Fields of papers citing papers by Robin E. Buckingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin E. Buckingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin E. Buckingham. The network helps show where Robin E. Buckingham may publish in the future.

Co-authorship network of co-authors of Robin E. Buckingham

This figure shows the co-authorship network connecting the top 25 collaborators of Robin E. Buckingham. A scholar is included among the top collaborators of Robin E. Buckingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin E. Buckingham. Robin E. Buckingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayward, A, Francesca Barone, Robin E. Buckingham, et al.. (2010). Peroxisome Proliferator-Activated Receptor-γ Agonist Rosiglitazone Prevents Albuminuria but Not Glomerulosclerosis in Experimental Diabetes. American Journal of Nephrology. 32(5). 393–402. 16 indexed citations
2.
Buckingham, Robin E. & Amir Hanna. (2007). Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?. Diabetes Obesity and Metabolism. 10(4). 312–328. 21 indexed citations
3.
Moore, Gary B.T., Lucy Pickavance, Celia P. Briscoe, et al.. (2007). Energy restriction enhances therapeutic efficacy of the PPARγ agonist, rosiglitazone, through regulation of visceral fat gene expression. Diabetes Obesity and Metabolism. 10(3). 251–263. 5 indexed citations
4.
Gruden, Gabriella, A Hayward, David Sugden, et al.. (2005). Mechanical Stretch Induces Monocyte Chemoattractant Activity via an NF-κB-Dependent Monocyte Chemoattractant Protein-1-Mediated Pathway in Human Mesangial Cells. Journal of the American Society of Nephrology. 16(3). 688–696. 76 indexed citations
5.
Gruden, Gabriella, A Hayward, David Sugden, et al.. (2003). Rosiglitazone prevents stretch-induced monocyte recruitment by inhibiting the NFkB-MCP1 pathway in human mesangial cells.. Diabetologia. 46. 2 indexed citations
6.
Hockings, Paul, K. Kumar Changani, Noha M. Saeed, et al.. (2003). Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in Zucker fatty rats. Diabetes Obesity and Metabolism. 5(4). 234–243. 54 indexed citations
7.
Carpentier, André C., Changiz Taghibiglou, Nathalie Leung, et al.. (2002). Ameliorated Hepatic Insulin Resistance Is Associated with Normalization of Microsomal Triglyceride Transfer Protein Expression and Reduction in Very Low Density Lipoprotein Assembly and Secretion in the Fructose-fed Hamster. Journal of Biological Chemistry. 277(32). 28795–28802. 86 indexed citations
8.
Cole, Mark A., et al.. (2001). Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart. Diabetologia. 44. 3 indexed citations
9.
Buckingham, Robin E., et al.. (2000). Rosiglitazone reduces hepatic fat content. Diabetologia. 43. 2 indexed citations
10.
Albarazanji, Kamal, Jonathan R.S. Arch, Robin E. Buckingham, & Mohammad Tadayyon. (2000). Central Exendin‐4 Infusion Reduces Body Weight without Altering Plasma Leptin in (fa/fa) Zucker Rats. Obesity Research. 8(4). 317–323. 171 indexed citations
11.
Haynes, Andrea, Brian A. Jackson, Philip Overend, et al.. (1999). Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides. 20(9). 1099–1105. 263 indexed citations
12.
Cutler, David J., Richard Morris, S. Holmes, et al.. (1999). Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord☆. Peptides. 20(12). 1455–1470. 194 indexed citations
13.
Buckingham, Robin E., et al.. (1998). Indices of Carbohydrate and Lipid Metabolism in Vasopressin-Replete and -Deficient New Zealand Genetically Hypertensive Rats. Hormone and Metabolic Research. 30(12). 717–720. 1 indexed citations
14.
Haynes, Andrea, et al.. (1998). Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?. Regulatory Peptides. 75-76. 355–361. 45 indexed citations
15.
Chen, Bing, David Hopkins, Qiong Wang, et al.. (1998). Direct Stimulation of BAT Thermogenesis Does Not Affect Hypothalamic Neuropeptide Y. Peptides. 19(1). 167–170. 6 indexed citations
16.
Widdowson, Peter, et al.. (1998). Acute Hyperleptinemia Does Not Modify Insulin Sensitivityin vivoin the Rat. Hormone and Metabolic Research. 30(5). 259–262. 14 indexed citations
17.
Widdowson, Peter, et al.. (1997). Reciprocal regional changes in brain NPY receptor density during dietary restriction and dietary-induced obesity in the rat. Brain Research. 774(1-2). 1–10. 75 indexed citations
18.
Widdowson, Peter, Robin E. Buckingham, & G. Williams. (1997). Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3–36) binding sites in rat brain: possible relationship to Y5 NPY receptors. Brain Research. 778(1). 242–250. 28 indexed citations
19.
Buckingham, Robin E., et al.. (1989). Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. British Journal of Pharmacology. 97(1). 57–64. 107 indexed citations
20.
Buckingham, Robin E.. (1988). Studies on the anti‐vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine. British Journal of Pharmacology. 93(3). 541–552. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John C. Clapham Breakdown of academic impact, for papers by Martin Heni Breakdown of academic impact, for papers by Björn Lemmer Breakdown of academic impact, for papers by Stefan Trapp Breakdown of academic impact, for papers by Judith Harvey‐White Breakdown of academic impact, for papers by Jean‐Pierre Maffrand Breakdown of academic impact, for papers by Alessandro Pocai Breakdown of academic impact, for papers by William J. Louis Breakdown of academic impact, for papers by Anders Fink‐Jensen Breakdown of academic impact, for papers by Mariano Ruiz‐Gayo
Rankless by CCL
2026